KCT0005330招募中未知
Relevant Use of Factor Xa inhibitor in Patients with Non-Valvular Atrial Fibrillation (RESPIRE trial): a multicenter, prospective, non- interventional, observational study
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 19(Year) 至 0No Limit（—）
- 性别
- All
入选标准
- •1)Males and females over 19 years old
- •2)Patients diagnosed with NVAF
- •3)Patients with CHA2DS2-VASc score of 1 (2 for females)
- •* CHA2DS2-VASc score: Assess the risk of stroke up to 9 points by considering the following factors: Congestive heart failure (+1 point), Hypertension (+1 point), Age 75 or over (+2 points), Diabetes mellitus (+1 point), Stroke (+2 points), Transient Ischemic Attack (TIA)/Thromboembolism (TE), Vascular disease (+1 point each), Age 65-74 (+1 point), and Sex (+1 point for females).[6]
- •4)When the investigator determines that the use of an anticoagulant is necessary to prevent stroke or systemic embolism
- •5)Patients who have no history of taking medications containing Apixaban within 6 months of screening
- •6)When the patients who understand the description of this study, agree to participate in the study, and completed/submitted the informed consent form
排除标准
- •1)Patients who are contraindicated according to the precautions for using Apixaban
- •2)Pregnant and lactating women
研究者
相似试验
已完成
3 期
The effect of oral rivaroxaban in treating and in the long term prevention in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.Pulmonary embolismDeep vein thrombosisCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12607000222448Bayer Australia Limited5,193
已完成
不适用
Reversal of oral direct factor Xa inhibitors rivaroxaban and apixaban by two different dosages of prothrombin complex concentrate (Cofact®)use of anticoagulation10047075NL-OMON37035Academisch Medisch Centrum12
招募中
不适用
se of Analgesics in the treatment of Oral Sub Mucous FibrosisCTRI/2022/03/041108Applied for intramural grant RIMS Ranchi
已完成
不适用
FACTOR Xa INHIBITORS FOR VENOUS THROMBOEMBOLISM MANAGEMENT IN PATIENT WITH CANCER: A META-ANALYSISIn Cancer patients with VTE or risk of VTEJPRN-UMIN000040346Dr. Soetomo General Hospital2,000
招募中
不适用
Anti-factor Xa assay in patients with atrial fibrillatioAtrial fibrillationJPRN-UMIN000046323Yamagata University School of Medicine Department of cardiology210